Viewing Study NCT00315757


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-01-04 @ 7:13 AM
Study NCT ID: NCT00315757
Status: COMPLETED
Last Update Posted: 2013-08-08
First Post: 2006-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor: Human Genome Sciences Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module